Search Results - Barbara Pro
- Showing 1 - 11 results of 11
-
1
Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial by Francine Foss, Steven Horwitz, Barbara Pro, H. Miles Prince, Lubomir Sokol, Barbara Balser, Julie Wolfson, Bertrand Coiffier
Published in Journal of Hematology & Oncology (2016-03-01)Get full text
Article -
2
Erratum to: Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial by Francine Foss, Steven Horwitz, Barbara Pro, H. Miles Prince, Lubomir Sokol, Barbara Balser, Julie Wolfson, Bertrand Coiffier
Published in Journal of Hematology & Oncology (2017-09-01)Get full text
Article -
3
Liquid biopsy for molecular profiling in cutaneous T-cell lymphoma: a pilot feasibility study by Yoni Sacknovitz, Anna Sarah Erem, Joshua A. Kent, Maher Albitar, Tatyana Feldman, Barbara Pro, Seda S. Tolu, Alejandro A. Gru, Larisa Geskin
Published in Blood Neoplasia (2026-08-01)Get full text
Article -
4
Phase I study of novel SYK inhibitor TAK‐659 (mivavotinib) in combination with R‐CHOP for front‐line treatment of high‐risk diffuse large B‐cell lymphoma by Reem Karmali, Frederique St‐Pierre, Shuo Ma, Kelly D. Foster, Jason Kaplan, Xinlei Mi, Barbara Pro, Jane N. Winter, Leo I. Gordon
Published in eJHaem (2023-02-01)Get full text
Article -
5
P1124: DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA FROM THE PHASE 2 PRIMO TRIAL EXPANSION PHASE: OUTCOMES BY BASELINE HISTOLOGY by Neha Mehta-Shah, Eric Jacobsen, Pier Luigi Zinzani, Jasmine Zain, Monica Mead, Carla Casulo, Giuseppi Gritti, Lauren Pinter-Brown, Koji Izutsu, Sheila Waters, Jonathan Brammer, Barbara Pro, Steven Horwitz
Published in HemaSphere (2023-08-01)Get full text
Article -
6
Retrospective evaluation of R-EPOCH in the frontline treatment of adult patients with PTLD after solid organ transplant by Brian Cuzzo, Maegan Ford, Saagar Jain, Hua-Jay Cherng, Evelyn Orlando, Patrick Gould, Amy Song, Benjamin May, Yuxuan Chen, Govind Bhagat, Andrew H. Lipsky, Barbara Pro, Jennifer E. Amengual
Published in Blood Neoplasia (2025-05-01)Get full text
Article -
7
Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin’s lymphoma: the updated M.... by Paolo Anderlini, Rima Saliba, Sandra Acholonu, Sergio A. Giralt, Borje Andersson, Naoto T. Ueno, Chitra Hosing, Issa F. Khouri, Daniel Couriel, Marcos de Lima, Muzaffar H. Qazilbash, Barbara Pro, Jorge Romaguera, Luis Fayad, Frederick Hagemeister, Anas Younes, Mark F. Munsell, Richard E. Champlin
Published in Haematologica (2008-02-01)Get full text
Article -
8
Double hit & double expressor lymphomas: a multicenter analysis of survival outcomes with CD19-directed CAR T-cell therapy by Reem Karmali, Geoffrey Shouse, Pallawi Torka, Tamara K. Moyo, Jason Romancik, Stefan K. Barta, Rahul Bhansali, Jonathon B. Cohen, Nirav N. Shah, Joanna Zurko, Vaishalee P. Kenkre, Brian Hess, Deborah M. Stephens, Lindsey Fitzgerald, Thomas Ollila, Bukky Tabiti, Ishan Roy, Shuo Ma, Jane Winter, Barbara Pro, Jonathan Moreira, Alexey V. Danilov, Kevin David, Leo I. Gordon, Narendranath Epperla
Published in Blood Cancer Journal (2025-03-01)Get full text
Article -
9
Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years’ follow-up by Eva Domingo-Domènech, Barbara Pro, Tim Illidge, Steven Horwitz, Lorenz Trumper, Swami Iyer, Ranjana Advani, Nancy L. Bartlett, Jacob Haaber Christensen, Won-Seog Kim, Tatyana Feldman, Ilseung Choi, Giuseppe Gritti, David Belada, Andrei Shustov, Arpad Illes, Pier Luigi Zinzani, Andreas Hüttmann, Marek Trneny, Steven Le Gouill, Deepa Jagadeesh, Jonathan W. Friedberg, Meredith Little, Cassie Dong, Michelle Fanale, Keenan Fenton, Kerry J. Savage
Published in Blood Cancer Journal (2025-08-01)Get full text
Article -
10
Posttransplant rituximab exposure and risk of PTLD in solid organ transplant recipients with EBV DNAemia by Evelyn H. Orlando, Patrick Gould, Brian Cuzzo, Maegan Ford, Yuxuan Chen, Alexander Sanjurjo, Saagar Jain, Benjamin May, Demetra Tsapepas, Rebecca J. Leeman-Neill, Govind Bhagat, Geoffrey K. Dube, Heather Morris, Selim Arcasoy, Farhana Latif, Ersilia M. DeFilippis, Mercedes Martinez, Gene Y. Im, Meaghan M. Phipps, Marcus R. Pereira, Paul K. Sue, Manuela Orjuela-Grimm, Andrew H. Lipsky, Ahmed Sawas, Ran Reshef, Barbara Pro, Hua-Jay J. Cherng, Jennifer E. Amengual
Published in Blood Neoplasia (2025-11-01)Get full text
Article -
11
Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle... by Julie M. Vose, Kai Fu, Lu Wang, Adnan Mansoor, Douglas Stewart, Hongxia Cheng, Lynette Smith, Ji Yuan, Hina Naushad Qureishi, Brian K. Link, Melissa H. Cessna, Paul M. Barr, Brad S. Kahl, Matthew S. Mckinney, Nadia Khan, Ranjana H. Advani, Peter Martin, Andre H. Goy, Tycel J. Phillips, Amitkumar Mehta, Manali Kamdar, Michael Crump, Barbara Pro, Christopher R. Flowers, Caron A. Jacobson, Sonali M. Smith, Deborah M. Stephens, Veronika Bachanova, Zhaohui Jin, Shishou Wu, Francisco Hernandez-Ilizaliturri, Pallawi Torka, Andrea Anampa-Guzmán, Farshid Kashef, Xing Li, Sunandini Sharma, Timothy C. Greiner, James O. Armitage, Matthew Lunning, Dennis D. Weisenburger, Robert G. Bociek, Javeed Iqbal, Guohua Yu, Chengfeng Bi, the North American Mantle Cell Lymphoma Consortium
Published in Journal of Hematology & Oncology (2023-12-01)Get full text
Article
